V-Go
Payments companies reported to CMS as associated with V-Go. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with V-Go, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with V-Go
These are the largest totals companies reported as associated with V-Go. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Kalpana Reddy | Flushing, NY | Endocrinology, Diabetes & Metabolism | $17,601.77 |
| Perry Herson | Williston Park, NY | $12,910.20 | |
| Rosemarie Lajara | Plano, TX | Endocrinology, Diabetes & Metabolism | $7,341.34 |
| Maria Gutierrez Dorrington | Boynton Beach, FL | $7,129.17 | |
| Trisha Zeidan | Dayton, OH | Endocrinology, Diabetes & Metabolism | $6,735.87 |
| Minh Mach | Burbank, CA | $6,718.45 | |
| Nitesh Kuhadiya | Reno, NV | Endocrinology, Diabetes & Metabolism | $6,237.94 |
| Stella Ilyayeva | Rego Park, NY | Endocrinology, Diabetes & Metabolism | $5,785.81 |
| Stephan Kowalyk | Greensburg, PA | Endocrinology, Diabetes & Metabolism | $5,700.43 |
| David Pickering | Parkersburg, WV | Internal Medicine | $5,138.48 |
Prescribed V-Go?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.